Page last updated: 2024-08-07 23:12:26
Cytochrome P450 1A1
A cytochrome P450 1A1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P04798]
Synonyms
CYPIA1;
EC 1.14.14.1;
Cytochrome P450 form 6;
Cytochrome P450-C;
Cytochrome P450-P1;
Hydroperoxy icosatetraenoate dehydratase;
4.2.1.152
Research
Bioassay Publications (37)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (10.81) | 29.6817 |
2010's | 25 (67.57) | 24.3611 |
2020's | 8 (21.62) | 2.80 |
Compounds (70)
Drugs with Inhibition Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
melatonin | Homo sapiens (human) | Ki | 59.0000 | 1 | 1 |
5-methoxypsoralen | Homo sapiens (human) | IC50 | 0.0800 | 1 | 1 |
5-methoxypsoralen | Homo sapiens (human) | Ki | 0.0600 | 1 | 1 |
beta-naphthoflavone | Homo sapiens (human) | IC50 | 0.0540 | 1 | 1 |
ellipticine | Homo sapiens (human) | IC50 | 0.0193 | 1 | 1 |
emodin | Homo sapiens (human) | IC50 | 12.2500 | 1 | 1 |
furafylline | Homo sapiens (human) | Ki | 200.0000 | 1 | 1 |
khellin | Homo sapiens (human) | IC50 | 4.0200 | 1 | 1 |
khellin | Homo sapiens (human) | Ki | 3.8000 | 1 | 1 |
nisoxetine | Homo sapiens (human) | IC50 | 0.0079 | 1 | 1 |
1,4-phenylenebis(methylene)selenocyanate | Homo sapiens (human) | IC50 | 0.1000 | 1 | 1 |
purpurin | Homo sapiens (human) | IC50 | 5.5000 | 1 | 1 |
1,3-diphenyl-1-triazene | Homo sapiens (human) | IC50 | 8.0000 | 1 | 1 |
naphthazarin | Homo sapiens (human) | IC50 | 3.8200 | 1 | 1 |
naphthazarin | Homo sapiens (human) | Ki | 3.6600 | 1 | 1 |
plumbagin | Homo sapiens (human) | IC50 | 2.7700 | 1 | 1 |
plumbagin | Homo sapiens (human) | Ki | 2.5600 | 1 | 1 |
alpha-naphthoflavone | Homo sapiens (human) | IC50 | 2.4555 | 26 | 26 |
alpha-naphthoflavone | Homo sapiens (human) | Ki | 0.0450 | 1 | 1 |
tranylcypromine | Homo sapiens (human) | IC50 | 6.2000 | 1 | 1 |
pyrene | Homo sapiens (human) | IC50 | 0.0410 | 2 | 2 |
4,5'-dimethylangelicin | Homo sapiens (human) | Ki | 37.9000 | 1 | 1 |
proadifen hydrochloride | Homo sapiens (human) | IC50 | 19.0000 | 1 | 1 |
rutecarpine | Homo sapiens (human) | IC50 | 0.2600 | 1 | 1 |
2-methoxyestradiol | Homo sapiens (human) | Ki | 62.0000 | 2 | 2 |
pinocembrin | Homo sapiens (human) | IC50 | 7.9060 | 1 | 1 |
isopimpinellin | Homo sapiens (human) | IC50 | 0.0200 | 1 | 1 |
isopimpinellin | Homo sapiens (human) | Ki | 0.0120 | 1 | 1 |
5-hydroxyflavone | Homo sapiens (human) | IC50 | 4.0300 | 1 | 1 |
4-methoxyestradiol | Homo sapiens (human) | Ki | 149.0000 | 1 | 1 |
pirlindole | Homo sapiens (human) | IC50 | 36.0000 | 1 | 1 |
hesperetin | Homo sapiens (human) | IC50 | 2.7860 | 1 | 1 |
homoeriodictyol | Homo sapiens (human) | IC50 | 11.5545 | 2 | 2 |
eupatorin | Homo sapiens (human) | Ki | 0.2100 | 1 | 1 |
phellopterin | Homo sapiens (human) | IC50 | 0.5800 | 1 | 1 |
phellopterin | Homo sapiens (human) | Ki | 0.6200 | 1 | 1 |
karanjin | Homo sapiens (human) | IC50 | 1.3650 | 2 | 2 |
benzyl selenocyanate | Homo sapiens (human) | IC50 | 0.1000 | 1 | 1 |
5-hydroxy-3',4',6,7-tetramethoxyflavone | Homo sapiens (human) | IC50 | 1.3800 | 1 | 1 |
5-hydroxy-3',4',6,7-tetramethoxyflavone | Homo sapiens (human) | Ki | 1.4200 | 1 | 1 |
cirsiliol | Homo sapiens (human) | Ki | 0.8000 | 1 | 1 |
isosakuranetin | Homo sapiens (human) | IC50 | 2.1960 | 1 | 1 |
naringenin | Homo sapiens (human) | IC50 | 15.1670 | 1 | 1 |
eriodictyol | Homo sapiens (human) | IC50 | 10.9730 | 1 | 1 |
resveratrol | Homo sapiens (human) | IC50 | 22.6667 | 3 | 3 |
cannabidiol | Homo sapiens (human) | Ki | 0.1600 | 1 | 1 |
pongamol | Homo sapiens (human) | IC50 | 2.2300 | 1 | 1 |
pongamol | Homo sapiens (human) | Ki | 1.9600 | 1 | 1 |
uccf-029 | Homo sapiens (human) | IC50 | 0.0187 | 1 | 1 |
quercetin | Homo sapiens (human) | IC50 | 8.4364 | 5 | 5 |
quercetin | Homo sapiens (human) | Ki | 0.6600 | 1 | 1 |
formononetin | Homo sapiens (human) | IC50 | 100.0000 | 1 | 1 |
acacetin | Homo sapiens (human) | IC50 | 0.0830 | 2 | 2 |
acacetin | Homo sapiens (human) | Ki | 0.0450 | 1 | 1 |
apigenin | Homo sapiens (human) | IC50 | 0.4270 | 1 | 1 |
apigenin | Homo sapiens (human) | Ki | 0.3900 | 1 | 1 |
luteolin | Homo sapiens (human) | IC50 | 1.2490 | 1 | 1 |
luteolin | Homo sapiens (human) | Ki | 1.8967 | 2 | 3 |
chrysoeriol | Homo sapiens (human) | IC50 | 0.0948 | 2 | 2 |
kaempferol | Homo sapiens (human) | IC50 | 0.6320 | 1 | 1 |
kaempferol | Homo sapiens (human) | Ki | 0.7500 | 1 | 1 |
baicalein | Homo sapiens (human) | Ki | 1.2200 | 1 | 1 |
chrysin | Homo sapiens (human) | IC50 | 0.7215 | 2 | 2 |
chrysin | Homo sapiens (human) | Ki | 0.0420 | 1 | 1 |
diosmetin | Homo sapiens (human) | IC50 | 0.1400 | 1 | 1 |
diosmetin | Homo sapiens (human) | Ki | 0.0890 | 1 | 1 |
galangin | Homo sapiens (human) | IC50 | 0.0770 | 1 | 1 |
genkwanin | Homo sapiens (human) | Ki | 2.3400 | 1 | 1 |
3-methylquercetin | Homo sapiens (human) | IC50 | 0.0560 | 1 | 1 |
kaempferide | Homo sapiens (human) | IC50 | 0.1940 | 2 | 2 |
myricetin | Homo sapiens (human) | Ki | 0.3700 | 1 | 1 |
scutellarein | Homo sapiens (human) | Ki | 1.6400 | 1 | 1 |
tamarixetin | Homo sapiens (human) | IC50 | 0.1200 | 1 | 1 |
trans-2,3',4,5'-tetrahydroxystilbene | Homo sapiens (human) | IC50 | 15.0000 | 1 | 1 |
pterostilbene | Homo sapiens (human) | Ki | 0.5700 | 1 | 2 |
2,4,3',5'-tetramethoxystilbene | Homo sapiens (human) | IC50 | 0.3000 | 3 | 3 |
3,3',4,5'-tetramethoxy-trans-stilbene | Homo sapiens (human) | IC50 | 0.7500 | 1 | 1 |
3,4',5-trimethoxystilbene | Homo sapiens (human) | IC50 | 0.8300 | 1 | 1 |
pinostilbene | Homo sapiens (human) | Ki | 0.1300 | 1 | 2 |
3,5-dihydroxy-4'-methoxystilbene | Homo sapiens (human) | Ki | 0.1600 | 1 | 2 |
eupatorin-5-methyl ether | Homo sapiens (human) | Ki | 0.6300 | 1 | 1 |
pifithrin-alpha | Homo sapiens (human) | IC50 | 1.5000 | 1 | 1 |
cannabidivarin | Homo sapiens (human) | IC50 | 0.0600 | 1 | 1 |
cannabidivarin | Homo sapiens (human) | Ki | 1.6000 | 1 | 1 |
kaf156 | Homo sapiens (human) | IC50 | 6.0000 | 1 | 1 |
Drugs with Activation Measurements
Drugs with Other Measurements
Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors.European journal of medicinal chemistry, , Jan-01, Volume: 209, 2021
Synthesis and structure-activity relationship studies of α-naphthoflavone derivatives as CYP1B1 inhibitors.European journal of medicinal chemistry, , Feb-01, Volume: 187, 2020
Development of benzochalcone derivatives as selective CYP1B1 inhibitors and anticancer agents.MedChemComm, , Sep-01, Volume: 10, Issue:9, 2019
Design and synthesis of selective CYP1B1 inhibitor via dearomatization of α-naphthoflavone.Bioorganic & medicinal chemistry, , 01-15, Volume: 27, Issue:2, 2019
Targeting Cytochrome P450 (CYP) 1B1 Enzyme with Four Series of A-Ring Substituted Estrane Derivatives: Design, Synthesis, Inhibitory Activity, and Selectivity.Journal of medicinal chemistry, , 10-25, Volume: 61, Issue:20, 2018
Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity.ACS medicinal chemistry letters, , Dec-13, Volume: 9, Issue:12, 2018
[no title available]Bioorganic & medicinal chemistry, , 12-15, Volume: 26, Issue:23-24, 2018
Identification of karanjin isolated from the Indian beech tree as a potent CYP1 enzyme inhibitor with cellular efficacy MedChemComm, , Feb-01, Volume: 9, Issue:2, 2018
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Quinazoline derivatives as selective CYP1B1 inhibitors.European journal of medicinal chemistry, , Apr-21, Volume: 130, 2017
Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.Bioorganic & medicinal chemistry letters, , 08-15, Volume: 27, Issue:16, 2017
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines.European journal of medicinal chemistry, , Mar-31, Volume: 129, 2017
[no title available]Bioorganic & medicinal chemistry letters, , 12-15, Volume: 27, Issue:24, 2017
(E)-3-(3,4,5-Trimethoxyphenyl)-1-(pyridin-4-yl)prop-2-en-1-one, a heterocyclic chalcone is a potent and selective CYP1A1 inhibitor and cancer chemopreventive agent.Bioorganic & medicinal chemistry letters, , 12-15, Volume: 27, Issue:24, 2017
A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.Journal of medicinal chemistry, , Aug-27, Volume: 58, Issue:16, 2015
Design and Synthesis of New α-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.Journal of medicinal chemistry, , Apr-23, Volume: 58, Issue:8, 2015
Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.Journal of medicinal chemistry, , May-23, Volume: 56, Issue:10, 2013
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Bioorganic & medicinal chemistry, , Aug-01, Volume: 15, Issue:15, 2007
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Bioorganic & medicinal chemistry, , Aug-01, Volume: 15, Issue:15, 2007
Quinazoline derivatives as selective CYP1B1 inhibitors.European journal of medicinal chemistry, , Apr-21, Volume: 130, 2017
[no title available]Bioorganic & medicinal chemistry letters, , 12-15, Volume: 27, Issue:24, 2017
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Bioorganic & medicinal chemistry, , Aug-01, Volume: 15, Issue:15, 2007
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Pyranoflavones: a group of small-molecule probes for exploring the active site cavities of cytochrome P450 enzymes 1A1, 1A2, and 1B1.Journal of medicinal chemistry, , May-23, Volume: 56, Issue:10, 2013
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.Bioorganic & medicinal chemistry, , May-01, Volume: 19, Issue:9, 2011
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Selective inhibition of methoxyflavonoids on human CYP1B1 activity.Bioorganic & medicinal chemistry, , Sep-01, Volume: 18, Issue:17, 2010
Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.Bioorganic & medicinal chemistry, , Aug-01, Volume: 15, Issue:15, 2007
Adaptable Small Ligand of CYP1 Enzymes for Use in Understanding the Structural Features Determining Isoform Selectivity.ACS medicinal chemistry letters, , Dec-13, Volume: 9, Issue:12, 2018
Inhibitors of cytochrome P450 (CYP) 1B1.European journal of medicinal chemistry, , Jul-28, Volume: 135, 2017
Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.Journal of medicinal chemistry, , Jan-03, Volume: 45, Issue:1, 2002
Enables
This protein enables 20 target(s):
Target | Category | Definition |
monooxygenase activity | molecular function | Catalysis of the incorporation of one atom from molecular oxygen into a compound and the reduction of the other atom of oxygen to water. [ISBN:0198506732] |
iron ion binding | molecular function | Binding to an iron (Fe) ion. [GOC:ai] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
arachidonic acid monooxygenase activity | molecular function | Catalysis of the incorporation of one atom from molecular oxygen into arachidonic acid and the reduction of the other atom of oxygen to water. [GOC:mah] |
oxidoreductase activity | molecular function | Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced. [GOC:go_curators] |
oxidoreductase activity, acting on diphenols and related substances as donors | molecular function | Catalysis of an oxidation-reduction (redox) reaction in which a diphenol or related substance acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor. [GOC:ai] |
flavonoid 3'-monooxygenase activity | molecular function | Catalysis of the reaction: a flavonoid + NADPH + H+ + O2 = 3'-hydroxyflavonoid + NADP+ + H2O. [EC:1.14.14.82] |
oxygen binding | molecular function | Binding to oxygen (O2). [GOC:jl] |
enzyme binding | molecular function | Binding to an enzyme, a protein with catalytic activity. [GOC:jl] |
heme binding | molecular function | Binding to a heme, a compound composed of iron complexed in a porphyrin (tetrapyrrole) ring. [GOC:ai] |
Hsp70 protein binding | molecular function | Binding to a Hsp70 protein, heat shock proteins around 70kDa in size. [ISBN:0198506732] |
demethylase activity | molecular function | Catalysis of the removal of a methyl group from a substrate. [GOC:mah] |
Hsp90 protein binding | molecular function | Binding to Hsp90 proteins, any of a group of heat shock proteins around 90kDa in size. [GOC:ai] |
aromatase activity | molecular function | Catalysis of the reduction of an aliphatic ring to yield an aromatic ring. [GOC:cb] |
vitamin D 24-hydroxylase activity | molecular function | Catalysis of the hydroxylation of C-24 of any form of vitamin D. [GOC:BHF, GOC:mah, PMID:15546903] |
estrogen 16-alpha-hydroxylase activity | molecular function | Catalysis of the reaction: estrogen + donor-H2 + O2 = 16-alpha-hydroxyestrogen + H2O. [GOC:BHF] |
estrogen 2-hydroxylase activity | molecular function | Catalysis of the reaction: estrogen + donor-H2 + O2 = 2-hydroxyestrogen + H2O. [GOC:BHF, GOC:rl, PMID:14559847] |
long-chain fatty acid omega-hydroxylase activity | molecular function | Catalysis of the reaction: an omega-methyl-long-chain fatty acid + O2 + reduced [NADPH--hemoprotein reductase] = an omega-hydroxy-long-chain fatty acid + H+ + H2O + oxidized [NADPH--hemoprotein reductase]. [GOC:krc, PMID:18544608, RHEA:56748] |
hydroperoxy icosatetraenoate dehydratase activity | molecular function | A hydroperoxy icosatetraenoate = an oxoicosatetraenoate + H2O. [PMID:12881489, RHEA:55556] |
long-chain fatty acid omega-1 hydroxylase activity | molecular function | Catalysis of the reaction: an (omega-1)-ethyl long-chain fatty acid + O2 + reduced [NADPH-hemoprotein reductase] = an (omega-1)-hydroxy-long-chain fatty acid + H+ + H2O + oxidized [NADPH-hemoprotein reductase. [GOC:nhn, PMID:18577768, PMID:22772592, PMID:24242247, RHEA:60936] |
Located In
This protein is located in 2 target(s):
Target | Category | Definition |
mitochondrial inner membrane | cellular component | The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae. [GOC:ai] |
endoplasmic reticulum membrane | cellular component | The lipid bilayer surrounding the endoplasmic reticulum. [GOC:mah] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
intracellular membrane-bounded organelle | cellular component | Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane. [GOC:go_curators] |
Involved In
This protein is involved in 40 target(s):
Target | Category | Definition |
response to hypoxia | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. [GOC:hjd] |
long-chain fatty acid metabolic process | biological process | The chemical reactions and pathways involving a long-chain fatty acid. A long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons. [GOC:ajp] |
lipid hydroxylation | biological process | The covalent attachment of a hydroxyl group to one or more fatty acids in a lipid. [GOC:hjd, PMID:15658937] |
fatty acid metabolic process | biological process | The chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis. [ISBN:0198547684] |
steroid biosynthetic process | biological process | The chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus; includes de novo formation and steroid interconversion by modification. [GOC:go_curators] |
porphyrin-containing compound metabolic process | biological process | The chemical reactions and pathways involving any member of a large group of derivatives or analogs of porphyrin. Porphyrins consists of a ring of four pyrrole nuclei linked each to the next at their alpha positions through a methine group. [GOC:jl, ISBN:0198506732, Wikipedia:Porphyrin#Natural_formation] |
xenobiotic metabolic process | biological process | The chemical reactions and pathways involving a xenobiotic compound, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. [GOC:cab2, GOC:krc] |
steroid metabolic process | biological process | The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus. [ISBN:0198547684] |
estrogen metabolic process | biological process | The chemical reactions and pathways involving estrogens, C18 steroid hormones that can stimulate the development of female sexual characteristics. Also found in plants. [ISBN:0198506732] |
amine metabolic process | biological process | The chemical reactions and pathways involving any organic compound that is weakly basic in character and contains an amino or a substituted amino group. Amines are called primary, secondary, or tertiary according to whether one, two, or three carbon atoms are attached to the nitrogen atom. [GOC:jl, ISBN:0198506732] |
response to nematode | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a nematode. [GOC:hb] |
response to herbicide | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a herbicide stimulus. Herbicides are chemicals used to kill or control the growth of plants. [GOC:curators] |
ethylene metabolic process | biological process | The chemical reactions and pathways involving ethylene (C2-H4, ethene), a simple hydrocarbon gas that can function in plants as a growth regulator. [ISBN:0387969845] |
coumarin metabolic process | biological process | The chemical reactions and pathways involving coumarins, compounds derived from the phenylacrylic skeleton of cinnamic acids. [GOC:lr, GOC:yl] |
flavonoid metabolic process | biological process | The chemical reactions and pathways involving flavonoids, a group of water-soluble phenolic derivatives containing a flavan skeleton including flavones, flavonols and flavanoids, and anthocyanins. [GOC:tair_curators, ISBN:0198547684] |
response to iron(III) ion | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron(III) ion stimulus. [GOC:sm] |
insecticide metabolic process | biological process | The chemical reactions and pathways involving insecticides, chemicals used to kill insects. [GOC:ai] |
dibenzo-p-dioxin catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of dibenzo-p-dioxin, a substance composed of two benzene rings linked by two ether bonds. [GOC:ai] |
epoxygenase P450 pathway | biological process | The chemical reactions and pathways by which arachidonic acid is converted to other compounds including epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids. [GOC:mah, PMID:17979511] |
response to food | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat. [GOC:add, ISBN:0721601464] |
response to lipopolysaccharide | biological process | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. [GOC:add, ISBN:0721601464] |
response to vitamin A | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin A stimulus. [GOC:sl] |
response to immobilization stress | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of being rendered immobile. [GOC:bf, PMID:17683801, PMID:19893991] |
vitamin D metabolic process | biological process | The chemical reactions and pathways involving vitamin D, any of a group of related, fat-soluble compounds that are derived from delta-5,7 steroids and play a central role in calcium metabolism. Specific forms of vitamin D include calciferol (ergocalciferol; vitamin D2) and cholecalciferol (calciol; vitamin D3). [GOC:mah, ISBN:0471331309] |
retinol metabolic process | biological process | The chemical reactions and pathways involving retinol, one of the three compounds that makes up vitamin A. [GOC:jl, http://www.indstate.edu/thcme/mwking/vitamins.html, PMID:1924551] |
long-chain fatty acid biosynthetic process | biological process | The chemical reactions and pathways resulting in the formation of a long-chain fatty acid. A long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons. [PMID:18390550] |
9-cis-retinoic acid biosynthetic process | biological process | The chemical reactions and pathways resulting in the formation of 9-cis-retinoic acid, a metabolically active vitamin A derivative. [GOC:jl, PMID:11279029] |
camera-type eye development | biological process | The process whose specific outcome is the progression of the camera-type eye over time, from its formation to the mature structure. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field. [GOC:go_curators, GOC:mtg_sensu] |
nitric oxide metabolic process | biological process | The chemical reactions and pathways involving nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water. [GOC:ai] |
response to arsenic-containing substance | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an arsenic stimulus from compounds containing arsenic, including arsenates, arsenites, and arsenides. [GOC:hjd, ISBN:0721662544] |
digestive tract development | biological process | The process whose specific outcome is the progression of the digestive tract over time, from its formation to the mature structure. The digestive tract is the anatomical structure through which food passes and is processed. [GOC:go_curators] |
tissue remodeling | biological process | The reorganization or renovation of existing tissues. This process can either change the characteristics of a tissue such as in blood vessel remodeling, or result in the dynamic equilibrium of a tissue such as in bone remodeling. [GOC:ebc] |
hydrogen peroxide biosynthetic process | biological process | The chemical reactions and pathways resulting in the formation of hydrogen peroxide (H2O2), a potentially harmful byproduct of aerobic cellular respiration which can cause damage to DNA. [GOC:ai] |
response to hyperoxia | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating increased oxygen tension. [GOC:kmv] |
maternal process involved in parturition | biological process | A reproductive process occurring in the mother that results in birth. [GOC:dph] |
hepatocyte differentiation | biological process | The process in which a relatively unspecialized cell acquires the specialized features of a hepatocyte. A hepatocyte is specialized epithelial cell that is organized into interconnected plates called lobules, and is the main structural component of the liver. [CL:0000182, PMID:7588884] |
cellular response to copper ion | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus. [GOC:mah] |
omega-hydroxylase P450 pathway | biological process | The chemical reactions and pathways by which arachidonic acid is converted to other compounds initially by omega-hydroxylation. [GOC:mw, PMID:10681399] |
positive regulation of G1/S transition of mitotic cell cycle | biological process | Any signaling pathway that increases or activates a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle. [GOC:mtg_cell_cycle] |
response to 3-methylcholanthrene | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 3-methylcholanthrene stimulus. [GO_REF:0000071, GOC:mr, GOC:TermGenie, PMID:9224771] |